The global blood grouping reagent market size was valued at USD 2,541 billion in 2021 and is poised to grow at a significant CAGR of 7.73% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Blood Grouping Reagent Market: by Product (Consumables, Instruments), by Technique (PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Other Techniques), by Test Type (Antibody Screening, HLA Typing, Cross-Matching Tests, ABO Blood Tests, Antigen Typing), by End-user (Hospitals, Blood Banks, Clinical Laboratories) and Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa) - Global/Region/Country Forecast to 2028”.

View detailed report description at https://precisionbusinessinsights.com/market-reports/global-blood-grouping-reagents-market/

Increase in the government initiatives about the need of blood donation is boosting the Blood Grouping Reagents Market

Blood grouping reagent market report covers unmet needs, latest trends, drivers and restraints which are presently affecting the market. It further goes on to track startup’s details, latest innovations and latest developments which are actively working in the market. Plethora of important data regarding regulatory framework, market entry strategies and reimbursement scenario is also depicted here. Blood grouping reagents are known as the necessary testing reagents employed by the blood banks and hospitals for to determine and identify antibody type in the blood of patient and donor for assuring the efficient and secure transfusion of blood as well as to lessen the danger of causing infections. Blood grouping reagents are suggested to determine ABO blood group and Rh type from the glood of donor. Antibiotics are used to make blood grouping reagents that are derived from in-vitro cultures of hybridomas of human and murin origin and even contains antigens to work against blood groups A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing.

There are a few factors that are fuelling the blood grouping reagents market growth such as campaigns on blood donation, increase in the occurrence rate of different illnesses, increasing government initiatives regarding the need of blood donation, dire requirement for the blood during surgical procedures and safe blood transfusions. But, the dearth of capable and trained professionals and lacking in the consciousness are the factors can lead to the risks in transfusion therefore, reducing the blood bank reagents growth worldwide.

Request sample research report at https://precisionbusinessinsights.com/request-sample?product_id=16010

North America dominates the Blood Grouping Reagent Market

Blood grouping reagents market is segmented into different regions including Europe, North America, Latin America, Middle East, Africa and Asia Pacific based on geographical regions. Among these regions, North America witnesses major market share because of the increasing cases of major blood disorders and favorable reimbursement policies for surgeries. Asia pacific market is expected to witness considerable growth rate because of increase in the occurrence and incidence rate of chronic disorders in Asian countries.

Competitive Analysis - Blood Grouping Reagent Market

There are a few major players working in the blood grouping reagent market such as Grifols, S.A. (Spain), Bio-Rad Laboratories, Inc. (U.S.), Immucor, Inc. (U.S.), Quotient, Ltd. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), BAG Healthcare GmbH (Germany), Day medical SA (Switzerland), Rapid Labs (U.K.), AXO Science (France) and DIAGAST (France).

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747